XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

STOCKHOLDERS’ EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity [Abstract] |
STOCKHOLDERS’ EQUITY | NOTE 6 - STOCKHOLDERS’ EQUITY Common Stock During the year ended December 31, 2023, the Company issued 9,644 shares of common stock for rounding of shares related to the Reverse Split. During the years ended December 31, 2022, the Company issued 18,912 shares of common stock for the conversion of notes and interest. Stock-Based Compensation The Company adopted an Employee, Director and Consultant Stock Plan on June 17, 2016 (the “2016 Plan”). Pursuant to the 2016 Plan, the Company’s Compensation Committee may grant awards to any employee, officer, director, consultant, advisor or other individual service provider of the Company or any subsidiary. Due to an annual “evergreen” provision in the 2016 Plan, the number of shares reserved for future grants was increased by 186,594 and 184,260 in 2023 and 2022, respectively. As a result of these increases, as of December 31, 2023 and December 31, 2022, the aggregate number of shares of common stock available for awards under the 2016 Plan was 1,279,181 shares and 1,543,872 shares, respectively. Options issued under the 2016 Plan are exercisable for up to ten years from the date of issuance. There were 1,357,466 options outstanding as of December 31, 2023. During the year ended December 31, 2023, the Company issued no options. There were 1,357,466 options outstanding as of December 31, 2022. The fair value of each stock option granted during the year ended December 31, 2022 was estimated using the Black-Scholes assumptions and or factors as follows: SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS
Exercise price |  | $ | 4.84 |
Expected dividend yield |  |  | 0 | %
Risk free interest rate |  |  | 1.73 | %
Expected life in years |  |  | 10 |
Expected volatility |  |  | 146 | %
The following is an analysis of the stock option grant activity under the Plan: SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY
|  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life |
Stock Options |  |  |  |  |  |  |  |  |  |  |  |
Outstanding December 31, 2021 |  |  | 1,380,216 |  |  | $ | 7.36 |  |  |  | 6.32 |
Granted |  |  | 12,500 |  |  |  | 4.84 |  |  |  | 9.02 |
Expired |  |  | (35,250 | ) |  |  | 6.09 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Outstanding December 31, 2022 |  |  | 1,357,466 |  |  | $ | 7.39 |  |  |  | 5.41 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Outstanding December 31, 2023 |  |  | 1,357,466 |  |  | $ | 7.39 |  |  |  | 4.49 |
A summary of the status of the Company’s nonvested options as of December 31, 2023, and changes during the years ended December 31, 2023 and 2022, is presented below: SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES
Nonvested Options |  | Options |  |  | Weighted-Average Exercise Price |
Nonvested at December 31, 2021 |  |  | 202,583 |  |  | $ | 12.32 |
Granted |  |  | 12,500 |  |  |  | 4.84 |
Vested |  |  | (96,896 | ) |  |  | 10.44 |
Forfeited |  |  | - |  |  |  | - |
Nonvested at December 31, 2022 |  |  | 118,187 |  |  | $ | 13.07 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (68,355 | ) |  |  | 11.87 |
Forfeited |  |  | - |  |  |  | - |
Nonvested at December 31, 2023 |  |  | 49,832 |  |  | $ | 14.72 |
As of December 31, 2023, the Company had 1,357,466 shares issuable under options outstanding at a weighted average exercise price of $7.39 and an intrinsic value of $0. The total number of options granted during the year ended December 31, 2023 and 2022 was 0 and 12,500, respectively. The exercise price for these options was $4.84 per share. The Company recognized compensation expense related to options issued of $666,828 and $844,248 for the years ended December 31, 2023 and 2022, respectively, in which $206,104 and $747,830 is included in general and administrative expenses and $460,724 and $96,418 in research and development expenses, respectively. For the years ended December 31, 2023 and 2022, $6,852 and $182,748 of the stock compensation was related to employees and $659,976 and $661,500 was related to non-employees, respectively. As of December 31, 2023, the unamortized stock option expense was $676,415 with $2,284 being related to employees and $674,131 being related to non-employees. As of December 31, 2023, the weighted average period for the unamortized stock compensation to be recognized is 3.55 years. Warrants: A summary of warrant issuances are as follows: SUMMARY OF WARRANT
|  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life |
Warrants |  |  |  |  |  |  |  |  |  |  |  |
Outstanding December 31, 2021 |  |  | 1,533,158 |  |  | $ | 13.52 |  |  |  | 3.15 |
Granted |  |  | 4,000 |  |  |  | 5.00 |  |  |  | 4.02 |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Outstanding December 31, 2022 |  |  | 1,537,158 |  |  | $ | 13.49 |  |  |  | 2.15 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | (594,592 | ) |  |  | 4.00 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Outstanding December 31, 2023 |  |  | 942,566 |  |  | $ | 19.47 |  |  |  | 2.31 |
As of December 31, 2023, the Company had 942,566 shares issuable under warrants outstanding at a weighted average exercise price of $19.47 and an intrinsic value of $0. The Company recognized compensation expense related to warrants issued of $0 and $20,433 during the years ended December 31, 2023 and 2022, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration